Thomas P. Loughran Jr, MD
Institution
UVA Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML)
Bradley H. Lewis, MD
Institution
Permanente Medical Group Inc
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Prognostic Significance of Monocytic-like Phenotype in AML patients treated with Venetoclax and Azacytidine
Original Publication Date
Article Source
External Web Content
Key Points Flow cytometry enhances morphological analysis to detect AML blasts with monocytic differentiation (mono-blasts). A high mono-blasts/CD45+ proportion cells predicts poor response and reduced survival in newly diagnosed AML patients receiving Ven-Aza The prognostic…
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
Original Publication Date
Article Source
External Web Content
Abstract The role of ABO blood group system mismatch on allogeneic hematopoietic cell transplantation (allo-HCT) outcomes is controversial since current publications of large datasets are lacking. We retrospectively analyzed 30,487 patients transplanted between 2010 and 2021…
Ross L. Levine, MD
Institution
Memorial Sloan-Kettering Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Daniel Landau, MD
Institution
MUSC Health University Medical Center Extension
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Hawk Kim, MD, PhD
Institution
Gachon University Gil Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Chronic Myelomonocytic Leukaemia (CMML)
Myelodysplastic Syndromes (MDS)
Rick J Jones, MD
Institution
Johns Hopkins University
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Status Update Support is Growing to Restore Funding to CDMRP and BMFRP Research Programs
Original Publication Date
Article Source
Status Update
Thanks to the efforts of our AAMDSIF bone marrow failure community and coalition partners, a bipartisan group of 105 U.S. House and 29 Senate members urged their leaders to restore funding to the Congressionally Directed Medical Research Programs ( CDMRP) including the Bone…
Raymond J. Hohl, MD, PhD
Institution
The Pennsylvania State University School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Graft Versus Host Disease (GVHD)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Hohl began his career at the University of Iowa, College of Medicine in 1991, where he served as assistant professor in the department of internal medicine. He became an assistant professor in the department of pharmacology in 1993 and was promoted to associate professor of both internal medicine and pharmacology in 1997. Dr. Hohl became the director of the division of hematology, oncology and blood and marrow transplantation at the Roy J. and Lucille A. Carver College of Medicine, University of Iowa in 1995. In 1999, he became the associate director for clinical research for the Holden